Bruce G. Allen Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$132K Sell
143
-6
-4% -$6.08K 0.09% 121
2025
Q4
$160K Sell
149
-39
-21% -$37.3K 0.11% 99
2025
Q3
$143K Buy
188
+6
+3% +$4.46K 0.1% 111
2025
Q2
$142K Sell
182
-29
-14% -$22.5K 0.11% 110
2025
Q1
$174K Hold
211
0.14% 82
2024
Q4
$163K Sell
211
-2
-0.9% -$1.66K 0.13% 90
2024
Q3
$189K Sell
213
-94
-31% -$84.5K 0.15% 81
2024
Q2
$278K Sell
307
-53
-15% -$42.4K 0.23% 54
2024
Q1
$280K Sell
360
-6
-2% -$4.27K 0.23% 56
2023
Q4
$213K Buy
+366
New +$214K 0.19% 68

Other funds holding LLY

Bruce G. Allen Investments's LLY Position: Q1 2026 in Review

Bruce G. Allen Investments reduced its Eli Lilly (LLY) stake by 4% in Q1 2026, selling an estimated $6.08K and leaving 143 shares worth $132K. The position accounts for 0.09% of the portfolio, ranked #121.

Bruce G. Allen Investments first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $280K in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bruce G. Allen Investments held 143 shares of Eli Lilly worth $132K as of Q1 2026.
  • Bruce G. Allen Investments sold 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
  • Eli Lilly made up 0.09% of Bruce G. Allen Investments's portfolio in Q1 2026, its #121 holding.
  • Bruce G. Allen Investments first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's Eli Lilly position peaked at $280K in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.